New data for Roche’s Susvimo demonstrates sustained efficacy in two serious diabetic eye conditions
Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
Yesafili, received marketing authorization approval from the European Commission for the European Union
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra
Purpose-built bioconjugation facility in Lonza’s Ibex Dedicate Biopark in Visp, Switzerland to support the potential commercial launch of Kodiak's lead product candidate KSI-301 for high-prevalence retinal diseases
Subscribe To Our Newsletter & Stay Updated